Perioperative and postoperative pain in patients undergoing subcutaneous implantable cardioverter-defibrillator placement

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The recent Avoiding Transvenous Leads in Appropriate Subjects (ATLAS) Trial demonstrated that the subcutaneous implantable cardioverter–defibrillator (S-ICD) reduces lead-related complications without significantly compromising the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisignani, A, Biffi, M, Caravati, F, La Greca, C, Tola, G, Palmisano, P, D'onofrio, A, Nigro, G, Sartori, P, Notarstefano, P, Vicentini, A, Valsecchi, S, Lovecchio, M, Bisignani, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
14.2 - Implantable Cardioverter-Defibrillator (ICD)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207397/
http://dx.doi.org/10.1093/europace/euad122.414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207397/
http://dx.doi.org/10.1093/europace/euad122.414

Ejemplares similares